A CDC vaccine advisory committee meeting scheduled for next week has been postponed. It was the first vaccine meeting since ...

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

The Advisory Committee on Immunization Practices (ACIP) meeting will be postponed to allow public comment prior to the ...

Shares of GSK PLC GSK rose 1.79% to £14.47 Thursday, on what proved to be an all-around rough trading session for the stock ...

Canada reported its first domestically acquired human case of bird flu on Nov. 9, 2024. The teenage patient became very ill, ...

“We are very impressed with Syngene’s professionalism, commitment to scientific excellence, and ability to deliver high-quality work on time,” said Allan Wehnert, CEO & Founder of Orocidin. “This ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

The Pharmaceutical Society of Nigeria, PSN, on Thursday, backed the National Agency for Food and Drug Administration's call ...

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.